Privia Health agreed to acquire Evolent Health's ACO business, serving over 120,000 lives, for $100 million cash.
Quiver AI Summary
Privia Health Group, Inc. has announced a definitive agreement to acquire an Accountable Care Organization (ACO) from Evolent Health, which manages care for over 120,000 lives through Medicare Shared Savings and other programs. This acquisition will expand Privia Health's reach to approximately 1.5 million attributed lives under various value-based care frameworks. Privia will pay $100 million in cash at closing, with up to an additional $13 million based on performance in 2025, and expects to close the deal in the fourth quarter of 2025. The transaction aims to enhance collaboration with healthcare providers, improve patient outcomes, and reduce costs by leveraging Privia's existing technology and services.
Potential Positives
- Privia Health Group's acquisition of an ACO business from Evolent Health expands its reach to approximately 1.5 million attributed lives in value-based care arrangements.
- This transaction is projected to contribute positively to Privia's Adjusted EBITDA in 2026, indicating potential growth and profitability.
- The acquisition enhances Privia's capability to offer its full suite of services and technology platform, providing synergies for ACO-participating providers.
- Privia Health's strategic move reinforces its position as a leading physician enablement company in the U.S. healthcare market, further supporting its mission to improve patient outcomes and lower costs.
Potential Negatives
- The acquisition involves a substantial cash outlay of $100 million upfront, plus potential additional payments, which could strain the company's financial resources.
- The company's reliance on performance-based payments from the Medicare Shared Savings Program introduces uncertainty regarding future financial performance.
- Challenges identified in the release, such as navigating a heavily regulated industry and potential compliance issues, could adversely affect operational stability and growth.
FAQ
What is the recent announcement from Privia Health Group?
Privia Health Group announced a definitive agreement to acquire an ACO business from Evolent Health, caring for over 120,000 lives.
How will the acquisition impact Privia Health's operations?
The acquisition will increase Privia Health's attributed lives in value-based care to approximately 1.5 million and enhance service offerings.
What is the financial aspect of the acquisition?
Privia Health will pay $100 million at closing and up to $13 million based on MSSP performance for 2025.
When is the transaction expected to close?
The transaction is anticipated to close in the fourth quarter of 2025, contributing positively to Adjusted EBITDA in 2026.
What is Privia Health's mission?
Privia Health aims to transform healthcare delivery to achieve better outcomes, lower costs, and improve community health.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PRVA Insider Trading Activity
$PRVA insiders have traded $PRVA stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $PRVA stock by insiders over the last 6 months:
- PARTH MEHROTRA (Chief Executive Officer) has made 0 purchases and 4 sales selling 62,147 shares for an estimated $1,487,343.
- DAVID MOUNTCASTLE (EVP & Chief Financial Officer) has made 0 purchases and 3 sales selling 12,397 shares for an estimated $289,388.
- MATTHEW SHAWN MORRIS sold 10,309 shares for an estimated $240,508
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PRVA Hedge Fund Activity
We have seen 152 institutional investors add shares of $PRVA stock to their portfolio, and 126 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 3,981,833 shares (-22.2%) from their portfolio in Q2 2025, for an estimated $91,582,159
- WELLINGTON MANAGEMENT GROUP LLP removed 1,650,288 shares (-88.4%) from their portfolio in Q2 2025, for an estimated $37,956,624
- BANK OF AMERICA CORP /DE/ removed 1,353,571 shares (-52.8%) from their portfolio in Q2 2025, for an estimated $31,132,133
- VAN BERKOM & ASSOCIATES INC. added 887,549 shares (+44.1%) to their portfolio in Q2 2025, for an estimated $20,413,627
- SOROS FUND MANAGEMENT LLC removed 700,000 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $15,715,000
- SILVERCREST ASSET MANAGEMENT GROUP LLC added 674,411 shares (+117.8%) to their portfolio in Q2 2025, for an estimated $15,511,453
- RIVERBRIDGE PARTNERS LLC removed 569,799 shares (-10.3%) from their portfolio in Q2 2025, for an estimated $13,105,377
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PRVA Analyst Ratings
Wall Street analysts have issued reports on $PRVA in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 08/29/2025
- Piper Sandler issued a "Overweight" rating on 08/11/2025
- Evercore ISI Group issued a "Outperform" rating on 07/09/2025
- JP Morgan issued a "Overweight" rating on 05/28/2025
- Baird issued a "Outperform" rating on 04/15/2025
- Truist Securities issued a "Buy" rating on 04/10/2025
- Needham issued a "Buy" rating on 04/10/2025
To track analyst ratings and price targets for $PRVA, check out Quiver Quantitative's $PRVA forecast page.
$PRVA Price Targets
Multiple analysts have issued price targets for $PRVA recently. We have seen 10 analysts offer price targets for $PRVA in the last 6 months, with a median target of $29.5.
Here are some recent targets:
- Jeff Garro from Stephens & Co. set a target price of $32.0 on 09/04/2025
- David M. Scharf from JMP Securities set a target price of $30.0 on 08/29/2025
- Sean Wieland from Piper Sandler set a target price of $36.0 on 08/11/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $28.0 on 07/09/2025
- Lisa Gill from JP Morgan set a target price of $32.0 on 05/28/2025
- Andrew Mok from Barclays set a target price of $24.0 on 05/27/2025
- Michael Ha from Baird set a target price of $26.0 on 04/15/2025
Full Release
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE: EVH). The ACO business cares for over 120,000 attributed lives through the Medicare Shared Savings Program (MSSP), as well as various commercial and Medicare Advantage programs. With this transaction, Privia Health will now serve approximately 1.5 million attributed lives in value-based care (VBC) arrangements across commercial, Medicare, Medicare Advantage and Medicaid.
Privia Health will pay $100 million in cash at closing and up to an additional $13 million subject to final MSSP performance for 2025. The transaction is expected to close in the fourth quarter of 2025, and is expected to positively contribute to Adjusted EBITDA in 2026. The Company will finance the transaction with cash on its balance sheet.
This strategic transaction increases VBC attributed lives in existing Privia states, adds lives in new states, and also offers a compelling synergy opportunity for the ACO-participating providers to join Privia’s Medical Groups for a full suite of services and technology platform.
“The addition of Evolent Health’s ACO business to our existing national network of ACOs reaffirms Privia Health’s ability to replicate our highly differentiated and flexible operating model with new provider partners across the U.S. ,” said Sam Starbuck, SVP and President, Privia Care Partners, Privia Health. “We look forward to collaborating with the physicians and their practices, and leveraging our population health and value-based care expertise to enhance the patient experience, improve outcomes and lower costs.”
About Privia Health
Privia Health™ is one of the largest physician enablement companies in the United States with a presence in 15 states and the District of Columbia. Privia builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. Privia collaborates with medical groups, health plans and health systems to optimize 1,300+ physician practices, improve the patient experience for 5.3+ million patients, and reward 5,100+ physicians and advanced practitioners for delivering high-value care.
Privia’s mission is to transform healthcare delivery to achieve better outcomes, lower costs, and improve the health of communities and the well-being of providers. For more information, visit priviahealth.com and connect with us on LinkedIn .
Safe Harbor Statement
This release may contain forward-looking statements within the meaning of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements relate to our current expectations, projections and assumptions about our business, the economy and future events or conditions. They do not relate strictly to historical or current facts. Forward-looking statements can be identified by words such as “aims,” “anticipates,” "assumes," “believes,” “estimates,” “expects,” “forecasts,” “future,” “intends,” “likely,” “may,” “outlook,” “plans,” “potential,” “projects,” “seeks,” “strategy,” “targets,” “trends,” “will,” “would,” “could,” “should,” and variations of such terms and similar expressions and references to guidance, although some forward-looking statements may be expressed differently. In particular, these include statements relating to, among other things: our future actions, business plans, objectives and prospects; and our future operating or financial performance and projections, including our full-year guidance for 2025. Factors or events that could cause actual results to differ may emerge from time to time and are difficult to predict. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results may differ materially from past results and those anticipated, estimated or projected. We caution you not to place undue reliance upon any of these forward-looking statements.
Factors related to these risks and uncertainties include, but are not limited to: the heavily regulated industry in which we operate, and any failure by us or our medical groups to comply with the extensive applicable healthcare laws and government regulations; the complexity of the legal framework governing our relationships with Medical Groups, some of which we do not own, and Privia providers, and the impact of legal challenges or shifting interpretations of applicable laws; the execution of our growth strategy, which may not prove viable and we may not realize expected results; difficulties timely implementing our proprietary end-to-end, cloud-based technology solution for Privia physicians and new medical groups; the high level of competition in our industry; challenges in successfully establishing a presence in new geographic markets; the impact of failures by or service disruptions at key third-party vendors, such as our primary electronic medical record vendor, athenahealth, Inc.; potential decreases in reimbursement rates by governmental and third-party payers, changes to payment terms or challenges negotiating and retaining favorable contracts with private third-party payers, and changes impacting our patient population; the financial and operational impact of our compliance with various complex and changing federal and state privacy and security laws and regulations related to our use, disclosure, and other processing of personal information and protected health information, including the Health Insurance Portability and Accountability Act of 1996; the impact of actual and potential security threats, cybersecurity incidents or privacy or other forms of data breaches involving us, our vendors or other third parties; the continued availability of qualified workforce, including staff at our medical groups, and the continued upward pressure on compensation for such workforce; and other risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2024 and the Company’s subsequent Quarterly Reports on Form 10-Q. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law.
Contact:
Robert Borchert
SVP, Investor & Corporate Communications
[email protected]
817.783.4841